Owlet, Inc. announced the addition of Melissa Gonzales to the Company?s Board of Directors. Gonzales brings more than 20 years of consumer and provider healthcare experience to Owlet, further advancing the Company as a leader in infant monitoring solutions. In her current role as President, Women?s Health at Myriad Genetics, Inc. Gonzales is responsible for serving consumers, patients and healthcare providers with genetic screens and tests that help women assess their risk of hereditary cancer and provide vital insights during pregnancy or when planning a family.

She is the Board Chair for March of Dimes, Chicago, a non-profit organization dedicated to improving maternal and infant health in the U.S. Prior to her role at Myriad, Gonzales was the Executive Vice President, Americas at Medela LLC, a global leader in breast pumps and medical solutions that supports millions of new moms and babies. During her 11 years with Medela, she helped position that company as the most trusted breast pump brand in North America. Earlier in her career, Gonzales led commercial teams at Align Technology and Smith & Nephew.